Stockwinners Market Radar for September 21, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:23 EDT Cathie Wood's ARK Investment bought 789K shares of Ginkgo Bioworks today

20:22 EDT DigitalBridge CEO buys $487K in common stock - In a regulatory filing, DigitalBridge disclosed that its CEO Marc Ganzi bought 32K shares of common stock on September 20th in a total transaction size of $487K.

19:05 EDT SVB's U.K. business becomes subsidiary bank - SVB Financial Group, the financial partner of the innovation economy and parent of Silicon Valley Bank, announced that its UK branch has become a wholly owned subsidiary of Silicon Valley Bank, due to significant growth of the business. Silicon Valley Bank UK Limited is led by CEO Erin Platts, formerly SVB's Head of EMEA and President of the UK Branch. As a full subsidiary, Silicon Valley Bank UK has appointed a UK Board of Directors to provide oversight for the business. Greg Becker, CEO of SVB Financial Group said: "At SVB, we have witnessed significant growth of the innovation economy in the UK over the past decade. Accordingly, SVB has also experienced outstanding growth in the UK leading to the transition to a subsidiary business based on our size. Under Erin's leadership and vision, we look forward to seeing Silicon Valley Bank UK continue to grow within the UK and Europe and bring the full power of the SVB platform to our innovative clients."

18:44 EDT M&T Bank raises prime lending rate to 6.25% from 5.50%, effective Sept. 22

18:28 EDT Twitter says it fixed bug impacting password resets on the platform - Twitter's Privacy Center said in a blog post: "We want to let you know that we recently fixed a bug that allowed Twitter accounts to stay logged in from multiple devices after a voluntary password reset. In order to help ensure the safety and security of everyone that may have been affected, we've proactively logged people who may have been affected out of active sessions. We take our responsibility to protect your privacy very seriously and it is unfortunate this happened. While there is no action for you to take, we want to share more about the steps we've taken and best practices for keeping your account safe...We learned of a bug that allowed some Twitter accounts to stay logged in on multiple mobile devices after a voluntary password reset. That means that if you proactively changed your password on one device, but still had an open session on another device, that session may not have been closed. Web sessions were not affected and were closed appropriately. This bug was introduced after we made a change to the systems that power password resets last year. We have directly informed the people we were able to identify who may have been affected by this, proactively logged them out of open sessions across devices, and prompted them to log in again. We realize this may be inconvenient for some, but it was an important step to keep your account safe and secure from potential unwanted access." Reference Link

18:15 EDT DBV Technologies trading resumes

18:01 EDT HSBC, affiliates raise prime, reference rate to 6.25% from 5.50%, effective 9/22

17:55 EDT Deutsche Bank increases prime lending rate to 6.25% - Deutsche Bank announced that its New York Branch, Deutsche Bank New York, and its affiliate Deutsche Bank Trust Company Americas have increased their prime lending from 5.50% to 6.25% effective tomorrow, September 22, 2022.

17:44 EDT DBV Technologies trading halted, news pending

17:33 EDT KB Home sees Q4 effective tax rate 24% - Sees Q4 average community count up 10%. Sees Q4 homebuilding operating income margin 16.7%. Sees Q4 housing gross profit margin 25%-26%. Sees Q4 SG&A expenses as a percentage of housing revenues of 8.8%. Says state of housing market has negatively impacted expectations for Q4. Comments and guidance taken from Q3 earnings conference call.

17:30 EDT Raytheon Technologies awarded $160.17M Navy contract - Raytheon was awarded a $160.17M firm-fixed-price, cost-plus-fixed-fee, and cost-only contract for Dual Band Radar, or DBR, design agent and technical engineering efforts. Engineering efforts and supplies are required to support the DBR systems installed aboard CVN-78 and DDG-1000 class ships. This contract includes options which, if exercised, would bring the cumulative value of this contract to $440,640,174. Work is expected to be completed by September 2023. If all options are exercised, work will continue through September 2027. This contract was not competitively procured in accordance with 10 U.S. Code 2304(c)(1) - only one responsible source and no other supplies or services will satisfy agency requirements. The Naval Sea Systems Command is the contracting activity.

17:18 EDT Salesforce jumps 2.5% to $151.25 after disclosing medium-term guidance

17:02 EDT Citizens Financial raises prime lending rate to 6.25% - Citizens Financial announced that Citizens Bank, N.A. has raised its prime lending rate to 6.25% from 5.50%, effective Thursday, September 22, 2022.

17:02 EDT Methanex announces TSX approval of 5% share repurchase program - Methanex announced that the Toronto Stock Exchange has approved the company's previously announced Normal Course Issuer Bid. Pursuant to the NCIB, the Company will purchase for cancellation up to 3,506,405 common shares, representing 5% of the 70,128,109 Shares issued and outstanding as of September 15, 2022. Purchases will be made on the open market through the facilities of the TSX and will commence on September 26, 2022 and end no later than September 25, 2023. Any purchases will be made from time to time at the then current market price of the Shares and all Shares purchased under the NCIB will be cancelled. Subject to certain exceptions for block purchases, any daily purchases under the NCIB through the TSX will not exceed 54,902 Shares, representing 25% of the Company's average daily trading volume on the TSX for the six month period ended on August 31, 2022. The Company intends to enter into an automatic securities purchase plan with its broker in connection with purchases to be made under the NCIB.

17:00 EDT Webster raise prime lending rate to 6.25% from 5.5% - Webster Financial Corporation, the holding company for Webster Bank, N.A. and its HSA Bank division, announced that it has raised its prime lending rate to 6.25% from 5.5%, effective Sept. 22, 2022.

16:41 EDT CVB Financial raises quarterly dividend to 20c per share from 19c - CVB Financial Corp. announced a 20c per share cash dividend with respect to the third quarter of 2022. This amounts to a quarterly dividend increase of 1c per share, compared to the 19c per share dividend for the second quarter of 2022, and represents the company's 132nd consecutive quarterly cash dividend. This dividend increase was approved at the company's regularly scheduled Board of Directors meeting held on September 21, 2022. The quarterly dividend will be payable on or about October 20, 2022 to shareholders of record as of October 5, 2022. "Our Company's strong levels of capital and liquidity, combined with our remarkable history of 181 consecutive quarters of profitability, has allowed us to pay cash dividends to our shareholders for 132 consecutive quarters," said David A. Brager, President and Chief Executive Officer. "We are pleased to be increasing our quarterly dividend by 5%. We believe this higher dividend, combined with our common stock repurchase plan, demonstrate our continuing commitment to provide strong returns to our shareholders."

16:37 EDT Ball Corp. completes sale of Russian beverage packaging business for $530M - Ball has completed the sale of its beverage packaging business in Russia to Arnest Group for $530M. The purchaser, Arnest Group, has acquired all of Ball's Russian-based business. Arnest is the largest manufacturer of perfume, cosmetic and household products in aerosol packaging in Russia and Ball's Aluminum Aerosol division has had the opportunity to work with the team at Arnest in the past. The closing of this transaction is not subject to any conditions, and all required approvals have been obtained. The sale is not expected to impact Ball's businesses outside of Russia.

16:34 EDT HarborOne Bancorp announces share repurchase program for up to 2.45M shares - HarborOne Bancorp "announced that its Board of Directors has adopted a share repurchase program. Under the share repurchase program, which has received regulatory approval, the Company may repurchase up to 2,450,208 shares of the Company's common stock, or approximately 5% of the Company's issued and outstanding shares following completion of the share repurchase program announced on April 12, 2022."

16:34 EDT TOP Ships effects 1-for 20 reverse stock split - TOP Ships announced that it has determined to effect a 1-for-20 reverse stock split of the Company's issued common shares. The Company's shareholders approved the reverse stock split and granted the Board the authority to determine the exact split ratio and when to proceed with the reverse stock split at the Company's Annual Meeting of Shareholders held on September 5. The reverse stock split is expected to take effect, and the Company's common stock will begin trading on a split-adjusted basis on the NASDAQ Capital Market, as of the opening of trading on Friday, September 23.When the reverse stock split becomes effective, every 20 shares of the Company's issued and outstanding common stock will be automatically combined into one issued and outstanding share of common stock without any change in the par value per share or the total number of authorized shares. This will reduce the number of outstanding shares of the Company's common stock from approximately 56.7 million shares to approximately 2.8M shares. No fractional shares will be issued in connection with the reverse split of the issued and outstanding common stock. Shareholders shall be paid cash-in-lieu of a fractional shares that occur as a result of the reverse stock split. Shareholders will receive instructions from the Company's exchange agent, American Stock Transfer & Trust Company, LLC, as to how to exchange existing share certificates for new certificates representing the post-reverse split shares.

16:32 EDT Lennar sees Q4 new orders 14,000-15,500 - Sees Q4: Deliveries of 20,000 - 21,000; Average sales price of $475,000-$480,000; Gross margin % on home sales of 26%-27%.

16:30 EDT Regions Bank raises prime lending rate to 6.25% from 5.5% - Regions Bank announced it is increasing the Regions prime lending rate to 6.25% from 5.50%, effective Thursday, Sept. 22.

16:17 EDT Nanobiotix sets recommended dose for planned NBTXR3 plus Anti-PD-1 study - Nanobiotix announced determination of the recommended phase 2 dose (RP2D) of NBTXR3 in combination with pembrolizumab or nivolumab for the treatment of patients suffering from inoperable locoregional recurrent (LRR) or recurrent and metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) that is resistant to prior immunotherapy. RP2Ds were determined for NBTXR3 plus pembrolizumab or nivolumab for patients with LRR or R/M HNSCC that has not received prior immunotherapy, lung metastases (mets) from any primary tumor, or liver mets from any primary tumor as well. The combined dose escalation and dose expansion parts of Study 1100 are expected to enroll up to 141 patients. The complete dose escalation part enrolled 29 patients in three cohorts: (i) head and neck lesions from LRR or R/M HNSCC eligible for anti-PD-1 therapy; (ii) lung mets from any primary cancer eligible for anti-PD-1 therapy; and (iii) liver mets from any primary cancer eligible for anti-PD-1 therapy. Study participants received a one-time intratumoral injection of NBTXR3 prior to their first radiotherapy session. They then received radiotherapy, followed by anti-PD-1. Based on the study's results, the RP2D for all three cohorts was determined to be 33% of gross tumor volume. Nanobiotix aims to deliver an industry-leading head and neck cancer treatment franchise powered by NBTXR3, and to replicate that approach across other solid tumor indications. Pursuant to this strategy, the Company has amended the ongoing expansion phase of Study 1100 to further strengthen the rationale behind a registrational protocol evaluating NBTXR3 plus anti-PD-1 for patients with R/M HNSCC that is resistant to prior immunotherapy.

16:15 EDT Citi raises base lending rate to 6.25% from 5.5% - Citibank, N.A. said it has raised its base lending rate to 6.25% from 5.50%, effective tomorrow, Thursday, September 22, 2022.

16:13 EDT KB Home reports Q3 backlog value up 9% to $5.26B - The company states: "Ending backlog value increased 9% to $5.26 billion. Ending backlog units were up slightly to 10,756. Reflecting lower demand stemming from higher mortgage interest rates, inflation and various other macroeconomic and geopolitical concerns, net orders of 2,040 and net order value of $979.0 million decreased 50% and 51%, respectively. Monthly net orders per community were 3.1, compared to 6.6."

16:12 EDT KB Home reports Q3 homes delivered up 6%, average selling price up 19% - The company states: "Homes delivered increased 6% to 3,615. Average selling price rose 19% to $508,700. Homebuilding operating income grew 91% to $325.1 million. The homebuilding operating income margin increased 610 basis points to 17.7% as a result of improvements in both the housing gross profit margin and selling, general and administrative expense ratio. Excluding total inventory-related charges of $8.5 million for the current quarter and $6.7 million for the year-earlier quarter, the homebuilding operating income margin was 18.1%, compared to 12.1%."

16:11 EDT Steelcase says pricing benefits exceeded inflation in Q2 - "Inflation continues to be significant and has aggregated to approximately $270 million over the last six quarters, but for the first time since fiscal 2021, our year-over-year pricing benefits exceeded inflation this quarter," said Dave Sylvester, senior vice president and CFO. "Over the coming quarters, although inflationary pressure is expected to remain, we anticipate the benefits from our pricing actions will continue to accumulate and more fully offset the cumulative inflationary costs we've incurred."

16:09 EDT Global Partners acquires Tidewater Convenience, terms not disclosed - Global Partners LP announced the purchase of Tidewater Convenience, Inc., further expanding the Partnership's retail footprint in the mid-Atlantic region. The acquisition includes 15 locations, 14 company-operated, in Southeast Virginia. "We are committed to continuing to expand by adding strategic locations to our vertically integrated network. Virginia is a key market that complements our existing portfolio," said Mark Cosenza, SVP Gasoline, Distribution and Station Operations. "We share Tidewater's values around community and a commitment to guest experience, and we look forward to continuing to deliver high-quality service at these locations."

16:08 EDT H.B. Fuller narrows FY22 adjusted EBITDA view to $540M-$550M from $530M-$550M - The company states: "Organic revenue growth for fiscal year 2022 is expected to be in the range of 17% to 18%, excluding the impact of the extra week; Adjusted EBITDA for fiscal 2022 is expected to be in the range of $540 to $550 million, up from the previously provided range of $530 to $550 million and equating to growth of 16% to 18% versus fiscal year 2021."

16:06 EDT Sterling awarded $45M site development contract for Rivian's new EV facility - Sterling Infrastructure (STRL) announced that its subsidiary, Plateau Excavation of its E-Infrastructure Solutions segment, has been awarded a $45M design-bid-build project by The Joint Development Authority of Jasper, Morgan, Newton and Walton Counties in Georgia. The first two phases of site development, which include 500 acres, are located in the East Atlanta Megasite for the Rivian (RIVN) Electric Vehicle plant. The Rivian EV Plant is another major project for Georgia, as the JDA has been instrumental in creating an atmosphere that fosters top-level developments in the area. Previous projects include Takeda and two Meta Data Centers, for which, Plateau has performed the sitework. This significant project expands Rivian's EV manufacturing operations and the state of Georgia's commitment to creating and sustaining a diversified economy. The project is scheduled to run from September 2022 through July 2023.

16:01 EDT Alnylam names Piyush Sharma CECO, Evan Lippman CDSO - Alnylam Pharmaceuticals announced the appointment of two new members to the management team - Piyush Sharma as Chief Ethics & Compliance Officer, and Evan Lippman in the newly created role of Chief Corporate Development and Strategy Officer. Both executives will report to Chief Executive Officer, Yvonne Greenstreet. "Attracting and retaining top talent is one of my top priorities, and I'm thrilled that Piyush and Evan are joining our team. Piyush brings valuable experience building robust compliance programs and infrastructure for global companies across a variety of industries. Evan brings deep corporate development and strategy expertise from his work across the pharmaceutical and other industries. In each case, their expertise will be invaluable as we continue to execute on our Alnylam P5x25 strategy," said Yvonne Greenstreet, MBChB, Chief Executive Officer of Alnylam. "I look forward to their counsel and contributions in the years ahead."

15:30 EDT KeyCorp raises prime lending rate to 6.25% - KeyCorp and its banking affiliates have raised their prime lending rate to 6.25% from 5.5%, effective tomorrow, September 22.

13:35 EDT DXC Technology trading resumes

13:20 EDT North American rail traffic down 1% for the week ending September 17 - The Association of American Railroads, AAR, reported U.S. rail traffic for the week ending September 17. For this week, total U.S. weekly rail traffic was 490,654 carloads and intermodal units, down 2.9% compared with the same week last year. Total carloads for the week ending September 17 were 239,528 carloads, up 2% compared with the same week in 2021, while U.S. weekly intermodal volume was 251,126 containers and trailers, down 7.3% compared to 2021. Five of the 10 carload commodity groups posted an increase compared with the same week in 2021. They included coal, up 3,948 carloads, to 72,774; nonmetallic minerals, up 2,491 carloads, to 35,163; and motor vehicles and parts, up 2,185 carloads, to 13,879. Commodity groups that posted decreases compared with the same week in 2021 included metallic ores and metals, down 3,192 carloads, to 21,581; miscellaneous carloads, down 1,623 carloads, to 8,250; and forest products, down 1,362 carloads, to 9,076. North American rail volume for the week ending September 17, on 12 reporting U.S., Canadian and Mexican railroads totaled 342,034 carloads, up 3.5% compared with the same week last year, and 341,595 intermodal units, down 4.7% compared with last year. Total combined weekly rail traffic in North America was 683,629 carloads and intermodal units, down 0.8%. North American rail volume for the first 37 weeks of 2022 was 25,025,034 carloads and intermodal units, down 2.4% compared with 2021. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP) and Trinity Industries (TRN), Greenbrier (GBX), FreightCar America (RAIL) and Wabtec (WAB). Reference Link

12:57 EDT Meta Platforms turns positive after WSJ report of 10% cost cuts

12:09 EDT ON Semiconductor expands silicon carbide fab in Czech Republic - onsemi celebrated the inauguration of its expanded silicon carbide fab in Roznov, Czech Republic. Starting in 2019, onsemi added SiC polished wafer and SiC epitaxy wafer production to its existing silicon polished and epitaxy wafer and die manufacturing in Roznov. Having outgrown the original site, reconstruction of a new building began last year to further expand wafer and SiC EPI manufacturing. Over the next two years, this expansion will increase the site's SiC production capabilities by 16 times and create 200 jobs by the end of 2024. So far onsemi has invested more than $150 million in the Roznov site and plans to spend an additional $300 million through 2023.

12:03 EDT Logitech G launches PRO racing wheel, pedals - Logitech G, a brand of Logitech, announced the PRO Racing Wheel and PRO Racing Pedals, "a stunning new professional-grade racing setup designed with and for professional sim drivers. Engineered for the most realistic and immersive racing experience possible, the PRO Racing Wheel features a new, high-performance Direct Drive engine along with TRUEFORCE feedback technology to deliver the most precise and pure connection to racing."

12:02 EDT Logitech G announces cloud first handheld gaming device - Logitech G, a brand of Logitech, announced the launch of the Logitech G CLOUD Gaming Handheld, a purpose-built gaming device for cloud gaming. The company says: "The new device includes precision gaming controls, a full 1080p HD screen, amazing battery life, and a lightweight, sleek form factor that enables players to enjoy libraries of PC and console games from the cloud in a fun, new way."

12:00 EDT AEA-Bridges Impact Corp. falls -11.3% - AEA-Bridges Impact Corp. is down -11.3%, or -$1.10 to $8.60.

12:00 EDT Ampex Corp falls -23.8% - Ampex Corp is down -23.8%, or -$2.62 to $8.38.

12:00 EDT Allego rises 10.9% - Allego is up 10.9%, or 59c to $6.00.

11:45 EDT CD Projekt says 'Cyberpunk 2077' says 1M daily players this week - CD Projekt (OTGLY) said that since its 2020 title "Cyberpunk 2077" recently released its Edgerunners update, the game has been visited by 1M players, both new and returning, each day of this week. The game is available on PC, PlayStation 5 (SONY), PS4, Xbox One (MSFT), and Xbox Series X/S. Reference Link

11:26 EDT Barstool Sportsbook to launch online in Ohio, iGaming NEXT's Buttler says - In a tweet, iGaming NEXT's Ryan Butler said that, "Barstool Sportsbook has been approved to launch online in Ohio Jan. 1, 2023; all four $PENN Entertainment casinos in the state are also expected to open in-person sportsbooks."Reference Link

11:05 EDT Keysight Technologies, Jiyun Technologies collaborate on battery test system - Keysight Technologies announced a collaboration with Jiyun Technologies to develop and deliver a tailored, compact battery test system for electric vehicles. Keysight delivered the tailored battery test system to Jiyun Technologies, which includes the company's regenerative power supplies, Data Acquisition System, Controller Area Network Interface Bus communication interfaces and other hardware products. The dedicated test software leveraged in the battery test system was adopted from Keysight's PathWave software portfolio, and the custom system can reach a maximum output voltage of 1000V, a current level of up to 540A and a maximum power level of 180kW.

11:00 EDT Salesforce, Zywave enter collaboration for insurance agency sales, service - Zywave announced a dedicated partnership and increased collaboration with Salesforce. This partnership will further bring together the worlds of insurance agency sales and client service, creating more efficient, strategic workflows powered by data and content to deliver a seamless client experience.

10:55 EDT Coinbase Cloud launches Node platform for web3 developers - In a blog post, Luv Kothari, group product manager at Coinbase Cloud and Sriram Raman, product manager at Coinbase Cloud said, "Web3 development is complex. One needs to learn new programming languages, blockchain technologies, and on top of that, there are many protocols to support. Coinbase Cloud is committed to helping Web3 developers do what they do best... BUIDL. That's why we're taking our experience developing Web3 products for DeFi, staking and blockchain infrastructure and making this technology accessible for free to developers around the world, starting with the launch of Node. Node empowers developers to build and monitor their Web3 applications from an easy-to-use platform with instant read/write access to blockchains and powerful data indexers to speed up responses. Node, formerly known as Query & Transact, has been serving dedicated, paid nodes to enterprises for read/write access to 25+ blockchains since 2020. Since then, we've been listening to the developer community and heard a demand for a developer version of Node. Which is why we are launching a free plan for developers building on Ethereum, providing self-serve and instant accessibility to blockchain nodes via API. Additionally, we are launching new Advanced APIs to simplify querying the blockchain and powerful new NFT APIs to developers around the world." Reference Link

10:20 EDT Cadiz announces wellfield expansion, completion of pipeline conversion study - Cadiz Inc. (CDZI) announced that it will begin construction of three new groundwater wells at Cadiz Ranch in October and initial engineering study for the conversion of the Company's 220-mile oil and gas pipeline to transport water has been completed. Once the three new wells are constructed and come online in early 2023, Cadiz will have 12 wells in operation with a total capacity of 36,000 acre-feet of water per year, a 33% increase over the current wellfield production capacity of 27,000 AFY. Cadiz retained global engineering firm Stantec (STN) to conduct the engineering study for the Northern Pipeline Project. The study identifies practical off-take locations, pumping stations, cleaning, retrofitting and other improvements that will enable the pipeline to be pressurized and convey approximately 25,000 AFY of water uphill from Cadiz to Barstow on its way to the State Water Project, and approximately 30,000 AFY downhill into Cadiz for storage.

10:05 EDT Boeing, Red 6 enter collaboration to develop aerial dogfighting technology - Boeing and augmented reality Red 6 announced they are collaborating to develop leading edge aerial dogfighting technology and training in advanced tactical aircraft. Boeing is the first company to team with Red 6 on this type of advanced training technology. The joint agreement sets the stage for future integration of Red 6's Advanced Tactical Augmented Reality System, and Augmented Reality Command and Analytic Data Environment into Boeing manufactured next-generation aircraft. The T-7 and F-15EX platforms could be among the first to receive ATARS and ARCADE. Using the system, pilots will be able to see and interact with augmented reality aircraft, targets, and threats on the ground or in the air while flying and training in their actual aircraft, reducing the cost of and need for multiple platforms and 'real world training exercises.'

10:02 EDT Northern Trust names Buzza global head, network managment, market strategy - Northern Trust announced the appointment of Michael Buzza as global head of Network Management & Market Strategy. Buzza, previously EMEA head of Market Advocacy and Innovation Research, will oversee the teams dedicated to providing market access and insights across the traditional securities services markets within the Digital Assets and Financial Markets group.

10:00 EDT XPeng falls -8.6% - XPeng is down -8.6%, or -$1.38 to $14.55.

10:00 EDT Freyr Battery rises 8.7% - Freyr Battery is up 8.7%, or $1.14 to $14.28.

10:00 EDT Annovis Bio rises 11.2% - Annovis Bio is up 11.2%, or $1.78 to $17.65.

09:58 EDT Neste finalizes transaction for JV with Marathon Petroleum - On 1 March 2022, Neste Corporation (NTIOY) and Marathon Petroleum Corporation (MPC) announced an agreement to establish a 50/50 joint venture to produce renewable diesel following a conversion project of Marathon's refinery in Martinez, California. All required closing conditions have been met, including the receipt of the necessary permits and regulatory approvals, and Neste and Marathon have today closed the transaction for the establishment of the joint venture to be called Martinez Renewables. Through Martinez Renewables, Neste obtains a 50% interest in the Martinez Renewable Fuels project. The facility will be operated by Marathon, and the production output will be split evenly between the joint venture partners. Upon completion, Martinez Renewables is expected to increase Neste's renewable products capacity by slightly over 1 million tons per annum. Martinez Renewables is expected to commence production in early 2023. Pretreatment capabilities are expected to come online in the second half of 2023 and the facility is expected to be capable of producing 2.1 million tons per year by the end of 2023.

09:48 EDT Amazon introduces new Fire HD 8 tablets - Amazon announced the next generation of Fire HD 8 tablets, launching four new models: Fire HD 8, Fire HD 8 Plus, Fire HD 8 Kids Pro, and Fire HD 8 Kids. Amazon said: "The all-new Fire HD 8, powered by a 30% faster processor and all-day battery life, provides customers with a premier entertainment experience and the ability to get more things done at home or on the go. And for the first time, customers can select a Disney Design bundle for the Fire HD 8 Kids featuring Mickey Mouse or Disney Princess cases. The new Fire HD 8 tablets are available for pre-order today and will begin shipping next month."

09:47 EDT Glatfelter falls -11.3% - Glatfelter is down -11.3%, or -53c to $4.14.

09:47 EDT Coty rises 6.3% - Coty is up 6.3%, or 49c to $8.28.

09:47 EDT Freyr Battery rises 9.8% - Freyr Battery is up 9.8%, or $1.29 to $14.43.

09:29 EDT OceanPal announces time charter contract with Hyundai Glovis - OceanPal announced that, through a separate wholly-owned subsidiary, it has taken delivery of the m/v Baltimore, a 2005 built Capesize dry bulk vessel of 177,243 dwt that the Company entered into an agreement to purchase in June 2022. The Company also announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Hyundai Glovis Co. Ltd, for m/v Baltimore, for a trip of about thirty-five days with agreed gross charter rate of $15,000 per day, minus a 5% commission paid to third parties. In the event that the trip duration exceeds forty days, the gross charter rate will be $18,000 per day, minus a 5% commission paid to third parties, for each additional day. The charter commenced earlier today. The employment of "Baltimore" is anticipated to generate approximately $600,000 of gross revenue for the scheduled period of the time charter.

09:19 EDT BetMGM, NBC Sports announce new partnership for 2022 NFL season - BetMGM, a sports betting and gaming entertainment partnership between MGM Resorts International (MGM) and Entain Plc (GMVHF), and Comcast's (CMCSA) NBC Sports announced a new partnership for the 2022 NFL season highlighted by weekly integrations on Football Night in America and content across other NBC Sports platforms. "It is a tremendous opportunity to partner with the talented team at NBC Sports and have the ability to engage with football fans nationwide. We look forward to delivering NBC viewers our BetMGM trading team insights as well as entertaining segments that showcase the excitement of betting with BetMGM," said Matt Prevost, Chief Revenue Officer, BetMGM. Will McIntosh, President, NBC Sports Next & Fandango, added: "As we continue to innovate within the rapidly growing sports-betting marketplace, this new partnership with BetMGM will allow NBC Sports to engage more fans across multiple platforms. We're looking forward to collaborating with BetMGM and are excited about the future activation opportunities this partnership will present." Reference Link

09:18 EDT BetMGM, NBC Sports announce new partnership for 2022 NFL season - BetMGM, a sports betting and gaming entertainment partnership between MGM Resorts International (MGM) and Entain Plc (GMVHF), and Comcast's (CMCSA) NBC Sports announced a new partnership for the 2022 NFL season highlighted by weekly integrations on Football Night in America and content across other NBC Sports platforms. "It is a tremendous opportunity to partner with the talented team at NBC Sports and have the ability to engage with football fans nationwide. We look forward to delivering NBC viewers our BetMGM trading team insights as well as entertaining segments that showcase the excitement of betting with BetMGM," said Matt Prevost, Chief Revenue Officer, BetMGM. Will McIntosh, President, NBC Sports Next & Fandango, added: "As we continue to innovate within the rapidly growing sports-betting marketplace, this new partnership with BetMGM will allow NBC Sports to engage more fans across multiple platforms. We're looking forward to collaborating with BetMGM and are excited about the future activation opportunities this partnership will present." Reference Link

09:17 EDT WPP acquires JeffreyGroup, terms undisclosed - WPP announced the acquisition of JeffreyGroup. JeffreyGroup will join the Hill+Knowlton Strategies international network and will create a communications agency presence in Latin America, doubling Hill+Knowlton Strategies' footprint in the region. Headquartered in Miami, with 330 people across offices in Mexico City, Brasilia, Rio de Janeiro, Sao Paulo and Buenos Aires, JeffreyGroup has been a powerhouse in Latin America for nearly three decades.

09:13 EDT Trimble Ventures invests in Civ Robotics, terms not disclosed - Trimble Ventures, Trimble's corporate venture capital fund, announced its investment in Civ Robotics, a San Francisco-based construction tech startup focusing on transforming surveying layout for civil engineering and infrastructure projects. This investment supports Trimble Ventures' mission to invest in early and growth-stage companies that are accelerating innovation, digital transformation and sustainability in the industries Trimble serves-such as agriculture, construction, geospatial and transportation. The investment terms were not disclosed.

09:12 EDT Ingredion names Noah Weiss as VP, investor relations, corporate communications - Ingredion Incorporated (INGR) announced that Noah Weiss has been named vice president, investor relations and corporate communications, effective September 6. In this capacity, Weiss will be responsible for the Company's investor relations strategy and serve as its leader with the investment community. Weiss will report to James Gray, executive vice president and CFO. Weiss brings more than 20 years of investor relations experience and joins the Company from CNH Industrial (CNHI), where he served in various roles for more than nine years, most recently as head of investor relations.

09:11 EDT Tuesday Morning closes transaction to secure $35M in convertible debt financing - Tuesday Morning announced the closing of its strategic transaction to secure $35M in convertible debt financing. The Transaction includes a $32M investment from a special purpose vehicle, SPV, formed by Ayon Capital and Retail Ecommerce Ventures, which is the owner of a diverse portfolio of consumer brands that includes Pier 1 Imports, Linens 'n Things, Stein Mart and Modell's Sporting Goods. The Transaction also includes $3M provided by certain members of Tuesday Morning's management team, including Chief Executive Officer Fred Hand. "We believe the closing of the Transaction provides Tuesday Morning with sufficient liquidity to pay down creditor and supplier obligations and sufficient liquidity to support operations moving forward," the company said. REV's founders, Tai Lopez and Dr. Alex Mehr, commented: "There is tremendous long-term opportunity for Tuesday Morning in the home goods and decor category, particularly as more homeowners and renters embrace online channels. We believe that being able to offer a high-touch omni-channel experience will become a differentiator for Tuesday Morning in the years to come. As a result of our investment and differentiated technology capabilities, we intend to help Tuesday Morning establish an ecommerce presence for the first time and seize 'white space' in the Company's growing addressable market. Our experienced and proven team, which has already identified strong synergies with our Pier 1 brand and its product catalogue, sees a viable path to unlocking enhanced value for all of the Company's shareholders. We look forward to working with management and pursuing a path towards long-term profitable growth." As previously announced, the Transaction results in a change in control of the Company. Tuesday Morning's nine-member Board of Directors will be reconstituted to be comprised of: Tai Lopez and Dr. Alex Mehr, who will serve as Co-Executive Chairs of the Board; Three additional directors designated by REV and Ayon; Three independent directors that are mutually agreed upon by REV, Ayon and the Board; and Chief Executive Officer and current director Fred Hand. The Company's management team is expected to remain in place.

09:10 EDT Samsung and Comcast team on 5G radio access network solutions - Samsung Electronics (SSNLF) and Comcast (CMCSA) announced that Comcast is working with Samsung to deliver 5G Radio Access Network solutions that can be used to enhance 5G connectivity for Xfinity Mobile and Comcast Business Mobile customers in Comcast service areas. Samsung will supply 5G RAN solutions for Comcast's efforts to deliver 5G access to consumer and business customers in the United States using Citizens Broadband Radio Service and 600MHz spectrum. Samsung 5G RAN products to be provided include radios for CBRS and 600MHz, baseband units, and a newly developed 5G CBRS Strand Small Cell that can be deployed on Comcast's aerial cable lines. Using the new compact and lightweight small cell product, cable operators like Comcast can more easily and cost-effectively provide 5G cellular connectivity by leveraging their existing DOCSIS infrastructure without having to build or acquire additional cell sites.

09:09 EDT AgileThought launches newest market unit: Media & Entertainment / US West - AgileThought (AGIL) announces the launch of its newest Market Unit: Media & Entertainment / US West that will focus serving the Technology, Media, and Telecom industry. In accordance with all other AgileThought Market Units, the formation of this new US West Unit has been defined via a combination of industries and geography in order to provide a focused and agile response to the needs of regional clients in this market. Driving this decision is the current makeup and size of the Technology, Media, and Telecom industries' market, which is currently estimated at $5.1 trillion. Leading this new Market Unit is Santiago Noziglia as SVP and General Manager. Santiago has more than 15 years of senior management experience, including a decade of strategic development and plan execution at technology organizations, most recently as Managing Director for Globant (GLOB).

09:07 EDT S&P Global and Novata announce strategic partnership - Novata, an ESG data platform built for the private markets, and S&P Global Market Intelligence announced a strategic partnership to provide private market investors with a holistic data solution that simplifies the process of collecting both financial and ESG data. Through this partnership, Novata's platform will be made available for S&P Global Market Intelligence customers to bridge their ESG data with financial data in order to provide a single source of insights. This proposed integration will help market participants make informed decisions about how ESG drives financial outcomes, and enable transparent communication to investors, auditors, boards and other key stakeholders. S&P Global is part of the consortium of organizations that supported Novata upon its launch in 2021.

09:06 EDT Fat Brands announces development deal for six stores in Sacramento area - FAT Brands announces a new development deal to open six new franchised locations in the Sacramento area. In partnership with franchisee Raj Pooni, the co-branded Fatburger and Buffalo's Express locations will open over the next six years with the first location set to open by the end of 2023.

09:05 EDT Tremor International appoints Chance Johnson as CCO - Tremor International (TRMR) announced the appointment of Chance Johnson as Chief Commercial Officer. In his new role, he will strengthen Tremor's strategic commercial partnerships across the industry, expand its enterprise business and connect new customers with the company's end-to-end technology stack. Following its recent acquisition of Amobee, a global advertising platform, Johnson will also lead Tremor's newly expanded advanced TV product line, which includes linear and CTV campaign planning tools. Johnson was most recently at Integral Ad Science (IAS), where he led the global sales and customer organization as Chief Revenue Officer. Johnson will report to Druker and is based out of the company's New York office.

09:04 EDT Bollinger Motors, Wabash announce joint development - Bollinger Motors, which recently became a majority owned company of Mullen Automotive (MULN), announces it has teamed up with Wabash (WNC) to develop a stronger, lighter, refrigerated truck body on electric chassis. Wabash has developed a lightweight composite technology, EcoNex Technology, for use in truck bodies and trailers that will integrate with Bollinger's Class 4 electric chassis cab. "I'm excited to help 'green up' the journey from farm to table," said Robert Bollinger, Founder & CEO of Bollinger Motors, who was inspired to start the company while he owned a farm in upstate New York. "We're confident Wabash's expertise in commercial transportation, combined with Bollinger's leadership in Class 4 electrification, will deliver a superior product for customers looking to reduce their carbon footprints."

09:02 EDT Warner Music appoints Robert Kyncl as CEO - Robert Kyncl has been appointed Chief Executive Officer of Warner Music Group (WMG), effective January 1, 2023. Kyncl currently serves as Chief Business Officer at YouTube (GOOG;GOOGL). To ensure a smooth leadership transition, Kyncl and current WMG CEO Steve Cooper will serve as Co-CEOs for the month of January 2023. As of February 1, 2023, Kyncl will become sole CEO of WMG and assume Cooper's board seat on WMG's Board of Directors.

09:02 EDT Warner Music names Robert Kyncl as CEO, starting January 1, 2023 - Robert Kyncl has been appointed CEO of Warner Music Group (WMG), effective January 1, 2023. Kyncl currently serves as Chief Business Officer at YouTube, where he's been instrumental in its phenomenal growth across all platforms. To ensure a smooth leadership transition, Kyncl and current WMG CEO Steve Cooper will serve as Co-CEOs for the month of January 2023. As of February 1, 2023, Kyncl will become sole CEO of WMG and assume Cooper's board seat on WMG's Board of Directors.

08:53 EDT Forza X1 announces details from collaboration with Garmin - Forza X1 (FRZA) announced details from its collaboration with Garmin (GRMN) to bring intuitive and interactive technology to the Company's first fully electric boat model, the FX1. Over the past several months, Forza and Garmin have worked together to develop a customized system driven by select Garmin products to prioritize ease of use and customer experience. Garmin's 22-inch GPSMAP 8622 multifunction display will be the high-tech command and control system in Forza's FX1 boats. The MFD's full high-definition touchscreen modernizes the FX1's helm by centralizing traditional controls. Features such as depth, heading, speed, along with GPS and detailed mapping will all be available in one place. The MFD also features Garmin's OneHelm platform, which brings together all the operations and capabilities of third-party devices, such as digital switching, and is anticipated to simplify the FX1's operation for owners.

08:48 EDT Atlas Corp. shareholder urges buyout group to raise bid to $16.50 per share - In a letter to the Atlas Corp. special committee, LF Partners' Charles Frischer said, "My name is Charles Frischer and my family owns common shares and call options in Atlas Corporation that give us an economic interest in more than 1,460,000 shares, an increase of 110,000 shares since my initial letter to your committee on August 15, 2022. It has now been more than 48 days since the buyout group led by David Sokol made their proposal to take the company private for $14.45 per share. In the initial proposal from Poseidon, they thought a deal could be reached in 2-3 weeks and we are now entering our 7th week since August 4. Given that we have no agreement to date, I would hate to believe that either the buyout group or the special committee has decided not to negotiate in good faith. In a letter to the special committee on September 9, 2022, I expressed my belief that based upon the value of the business and discussions with shareholders, there is a strong desire and willingness to get a transaction done at a price of $16.50 per share. I think it is entirely unreasonable for the buyout group not to raise their offer. It would be equally negligent for the special committee to expect an unreasonable price for the company as well. Some investors have asked me who does the special committee work for when it seems that $16.50 is a price that is both easily justifiable and acceptable to a majority of the minority of shareholders. If we were to learn that the special committee did not negotiate in good faith, for whatever reason, this would be a complete dereliction of their fiduciary duty to the minority shareholders. The special committee works on behalf of the minority shareholders and should not exist to insure that they maintain their board positions. I believe that minority shareholders want a fair deal, clearly above the $14.45 initial offer, and they will accept $16.50. Negotiating for more than $16.50 may not be in the interest of minority shareholders, especially if it risks not getting this deal completed. In the most recent Atlas Corporation annual report filing in March of 2022, the company reported that the entire Board of Directors, outside of Mr. Sokol and Mr. Chen, owned a total of only 1,545,000 shares. It is not acceptable for owners of no more than a few hundred thousand shares to control the 90 million shares owned by minority shareholders. I believe the special committee must, if available, bring a deal at $16.50 and then let the majority of the minority decide via a direct shareholder vote. My advice to the buyout group is to raise your bid to $16.50 to complete this acquisition. If the special committee is not willing to recommend that price to the minority shareholders, move ahead immediately with a tender offer at $16.50. This tender can have a requirement that you get enough shares to then do a short form merger once you control 90% of the shares. This would still be a fair and reasonable transaction in the spirit of Fairfax Financial's respect for minority shareholders. In the event that the special committee is not interested in negotiating fairly, do not let the potential desire of three small Atlas shareholders on the Board stop a fair transaction from happening."

08:43 EDT Fujifilm upgrades ASGE's IT&T with ELUXEO systems - FUJIFILM Healthcare Americas Corporation and the American Society for Gastrointestinal Endoscopy announce that ASGE has equipped its Chicago-based Institute for Training and Technology Advanced Bioskills Laboratory and Simulation Center with 16 of Fujifilm's ELUXEO Endoscopic Imaging Systems and twenty 700 Series Endoscopes. The suite of comprehensive endoscopy solutions was installed in late August and will be utilized throughout ASGE's live and virtual training programs for medical students and seasoned endoscopy professionals.

08:40 EDT Magnite, Group Black collaborate to help Black-owned media scale their offering - Group Black and Magnite announced their collaboration to help Black-owned media scale their programmatic offerings. The joint effort aims to produce an increased revenue engine for these Black-owned brands while also strengthening the value proposition for companies who choose to work within Group Black's collective. "We are thrilled to support Group Black's mission by providing Black-owned publishers with programmatic technology and tools, across various digital formats including display, video, CTV, DOOH, and audio, to help more effectively and efficiently manage and scale their advertising strategies," said Mike Laband, SVP of Programmatic Platforms at Magnite. "Magnite is collaborating with publishers to help create scaled packages for Group Black's buying community."

08:39 EDT Cheniere Energy promotes Corey Grindal COO - Cheniere Energy (LNG) and Cheniere Energy Partners (CQP) announced the promotion of Corey Grindal to Executive Vice President and Chief Operating Officer, effective January 2. As Executive Vice President and Chief Operating Officer, Grindal will lead the Operations, Engineering and Construction, Shared Services and Worldwide Trading organizations within Cheniere. In his new role, he will continue to report to Jack Fusco, President and Chief Executive Officer. Grindal will also serve as Executive Vice President and Chief Operating Officer at Cheniere Partners. Grindal will relocate back to Houston from London, where he has served as Executive Vice President, Worldwide Trading since 2020. Grindal joined Cheniere in 2013 and led the Gas Supply organization for the Company, which today is one of the largest holders of pipeline capacity and purchasers of natural gas in the United States.

08:38 EDT iRhythm details growth strategies at 2022 Analyst & Investor Day - iRhythm Technologies will discuss the Company's strategies for long-term growth, provide an update on its innovation pipeline and share its financial goals during its 2022 Analyst & Investor Day today in New York City. "We are incredibly excited to share our growth strategies, refreshed vision and mission, and our five-year financial targets that represent the future direction of iRhythm," said Quentin Blackford, President and Chief Executive Officer. "iRhythm has a strong foundation upon which we are building, and we see real potential to serve millions more patients. Our technology platform is well suited to meet the needs of an evolving healthcare landscape while transforming a market that has not been disrupted in the last ten years." As part of the Company's 2022 Analyst & Investor Day, iRhythm will be discussing the following: Key Highlights: The Company's five-year financial plan which aims to deliver ~20% revenue CAGR, driven by the core U.S. and entry into certain international markets, with planned expansion into adjacent markets offering potential upside; Significant leverage from gross margin and G&A cost savings anticipated to lead to an adjusted EBITDA margin of 15% in 2027; Refreshed Company vision and mission statements; Clinical priorities that include continued enhancements to the Company's core technology, products and services, augmenting clinical evidence, exploring and entering adjacent markets, and leveraging data science and AI; U.S. market expansion; International expansion roadmap focused on seven prioritized countries, yielding an anticipated market opportunity of more than $1 billion; Introduction of the Know Your Rhythm program, iRhythm's early detection program for early detection of heart arrythmias; Discussion of the Company's framework to continue to build products and technology for the future; Operational initiatives intended to allow the Company to continue to scale and improve business continuity, enhance patient and provider experience.

08:37 EDT Starwood Property and energyRe launch Radial Power joint venture - Starwood Energy Group Global and energyRe announced the launch of Radial Power. Radial Power will seek to deliver best-in-class portfolio-wide distributed clean energy solutions to large real estate and C&I asset owners, while unlocking revenues from underutilized real estate, delivering cost savings, and helping to facilitate North America's energy transition. Radial Power is a joint venture comprising investment affiliates of energyRe and Starwood Energy, respectively, the large-scale energy affiliates of the Related Companies. Investment affiliates of energyRe and Starwood Energy will be the direct investors in Radial Power. Starwood Capital and the Related Companies, which combined have approximately 2,000 assets across all real estate asset classes in more than 45 states valued in excess of $175B, anticipate becoming Radial Power's foundational customers for Radial Power's asset and regional specific solutions.

08:36 EDT iBio initiates review of opportunities to 'accelerate transformation' - In an effort to focus its resources on the promising new discovery platform and entering the clinic with its lead compounds, iBio has initiated a review of opportunities to accelerate its transformation while extending its cash runway beyond previous guidance of September 30, 2023. These include asset sales, partnerships, portfolio decisions, cost reductions, and non-dilutive efforts to raise additional capital.

08:34 EDT LogicBio Therapeutics announces results from editing therapy study - LogicBio Therapeutics announced that results from the company's preclinical research study entitled "Novel AAV-mediated genome editing therapy prevents metabolic decompensation in a mouse model of methylmalonic acidemia" have been published in the peer-reviewed journal PLOS ONE. MMA is a metabolic disorder most commonly caused by mutations in the methylmalonyl-CoA mutase gene. Patients with MMUT deficiency are currently treated with strict life-long dietary management to mitigate acute illness that worsens the patient's basal condition, particularly with respect to metabolic brain injury. Early-stage research has indicated that restoration of Mmut enzymatic activity by gene addition mediated by recombinant adeno-associated virus could be a promising approach in the treatment of MMUT deficiency in pediatric patients. In the study, researchers developed a novel protein-controlled diet regimen in a MMUT deficient mouse model of MMA that mimics the metabolic crises that MMA patients experience. Mice were treated with a single administration of mLB-001, a nuclease-free, promoterless recombinant AAV vector designed based on LogicBio's proprietary GeneRide platform to deliver the mouse MMUT into the endogenous albumin locus. Mice deficient in MMUT that were treated with the Generide AAV vector had attenuated body weight loss and were protected from mortality when challenged with a high protein diet.

08:32 EDT Whirlpool announces second Virtual Power Purchase Agreement - Whirlpool announced that it has entered into a second wind Virtual Power Purchase Agreement, or VPPA, to accelerate progress towards its commitment to reach Net Zero emissions in its plants and operations by 2030. This latest agreement with ENGIE North America will represent 53 megawatts of clean, renewable wind energy over 12 years. To meet its 2030 goals, Whirlpool Corp. is maximizing previous investments in onsite renewable energy and making energy-efficient upgrades across its manufacturing plants while also investing in off site renewable energy opportunities through Virtual Power Purchase Agreements that provide clean, renewable energy to the grid for its consumers.

08:24 EDT Stabilis Solutions receives DOE approval to export LNG - Stabilis Solutions announced that it has received authorization from the U.S. Department of Energy to export domestically produced liquefied natural gas to all free trade and non-free trade countries, including Asian, European, and Latin American importing nations. Under the DOE's order, Stabilis received authority to export on its own behalf, or as agent for others, up to the equivalent of 51.75 billion cubic feet per year of domestically produced LNG. The authorization is for a term of 28 years.

08:21 EDT Capstone Green Energy secures order for five C65 microturbine systems - Capstone Green Energy announced that E-Finity Distributed Generation, Capstone's exclusive distributor for the Mid-Atlantic, Southeastern United States and the Caribbean, has secured an order for five C65 microturbine systems to be deployed at various oil and gas wellhead sites in the Marcellus Shale region. The systems represent a second follow-on order from the customer and will be added to an already extensive fleet.

08:20 EDT XPeng launches G9 Flagship SUV in China - XPeng revealed the pricing and specifications for its 4th production model G9 Flagship SUV for the Chinese market. The G9 lineup includes three series - each with a different driving range - and six configurations in total. There will be three series of G9-each with a different driving range-and six configurations in total. These are the RWD 570G, RWD 570E, and RWD 702E; 4WD Performance 650E and 650X; and a Launch Edition 650X. The 4WD Performance models come with a dual-chamber air suspension system as standard. G9 will start from 309,900 up to 469,900 RMB with the first deliveries for customers in China expected in October.

08:20 EDT WSP Global completes acquisition of John Wood Group's E&I business - WSP Global (WSPOF) completed its previously announced acquisition of the Environment & Infrastructure business of John Wood Group (WDGJF), through a sale and purchase agreement. E&I provides engineering, remediation consulting, environmental permitting, inspection, monitoring, and environmental management services to government, industrial, infrastructure, oil and gas, power, water, and mining clients. E&I's 6,000 professionals are based in some 100 offices in over ten countries, mainly in the US, Canada, and the UK, with a secondary presence in Latin America and Europe. The aggregate cash consideration payable in connection with the Acquisition is approximately $1.801B, subject to adjustments. The Acquisition and other related transaction costs were financed using a $1.801B term credit facility with various tenors of up to five years in length.

08:14 EDT MaxCyte debuts new headquarters in Maryland's I-270 Biotech Corridor - MaxCyte announced that it has relocated its headquarters to 9713 Key West Avenue in Rockville, Maryland, 20850, within Maryland's I-270 Biotech Corridor. The Company's new facility increases its in-house manufacturing capacity, as well as research and process development lab space. "The State of Maryland and Montgomery County have worked relentlessly over several decades to cultivate a robust life sciences and biotech community, with MaxCyte playing a critical role in that development," said Doug Doerfler, President and CEO of MaxCyte. "As we continue our work toward transforming patients' lives globally, we remain committed to fearless innovation and scientific solutions that help our partners discover and develop life-saving therapeutics through the application of our unmatched technology platforms paired with outstanding support and expertise."

08:13 EDT AbCellera launches second phase of global headquarters expansion - AbCellera announced it has launched the second phase of its global headquarters expansion by breaking ground on its new facility in Vancouver, Canada. The 380,000-square-foot tech campus will include state-of-the-art lab and office spaces to support AbCellera's capabilities in bringing new antibody-based medicines from target to the clinic. The expansion will accommodate the growth of AbCellera's existing 450+ person team and the investments into forward integration of translational science, process development, and clinical manufacturing capabilities. "With our current capabilities, we are able to find optimal clinical antibody candidates with greater precision and speed, ultimately helping our partners bring medicines to patients sooner," said Murray McCutcheon, Ph.D., SVP, Corporate Development at AbCellera. "Upon completion of this expansion, AbCellera will stand alone in providing a fully integrated solution for partners to bring novel antibody-based medicines from target to the clinic. For many partners, integration allows them to focus resources on their core business."

08:12 EDT Seven Hills Realty Trust appoints Tiffany Sy as CFO - Seven Hills Realty Trust (SEVN) announced that Tiffany Sy has been appointed as Chief Financial Officer and Treasurer, effective October 1. Sy joined The RMR Group (RMR) in 2020 as a Senior Director, Accounting, and is responsible for various aspects of the accounting function supporting RMR and its clients, including SEVN. Ms. Sy has been promoted to a Vice President of RMR and has also been appointed Chief Financial Officer and Treasurer of Tremont Realty Capital, both effective October 1.

08:12 EDT Northrop Grumman meets rocket motor casting milestone - Northrop Grumman successfully cast the LGM-35A Sentinel program's first inert stage-one and stage-two solid rocket motor set this summer. The casting event demonstrated the maturity of Sentinel's solid rocket motor design and validated manufacturing processes, advanced tooling, and facilities. The Sentinel program used digital engineering tools that helped iterate motor designs earlier and faster, prior to building hardware, thus allowing the team to produce the motors more efficiently and with less risk. The casting event is one of several on-time manufacturing firsts for the program over the past year as the program prepares for first flight from Vandenberg Space Force Base, California. Sarah Willoughby, vice president and program manager, Sentinel, Northrop Grumman, said, "We are now building stage-one and stage-two solid rocket motors that will undergo static test fire, and the data from these tests will be combined with information from ongoing structural and wind tunnel performance testing to fine tune our digitally engineered models, in line with the Air Force development schedule."

08:10 EDT XpresSpa expands retail products for women - XpresSpa Group has launched the Women's Health Initiative as part of its overarching social responsibility platform strategy designed to advance the education and support of wellness for women. As part of this launch, the Company rolled out an expanded line of retail products dedicated to women's health including products in the personal hygiene, pregnancy prevention, reproductive health, first aid and wellness categories. "Women play a significant role shaping the trends we see in the wellness industry and have more choices than ever about the products they choose to buy. We want to deliver solutions that inform and serve their evolving lifestyles and meet their specific health and wellness needs," said XpresSpa Group CEO Scott Milford. "We have been very intentional in sourcing to offer high-quality, sustainable products from companies that support women and are owned by women and people of color. We are excited to expand our offerings for women on the go."

08:08 EDT Williams Industrial Services, Eversource enter MSA - Williams Industrial Services (WLMS) announced that it has entered into a master service agreement, or MSA, with Eversource Energy (ES), a major New England utility based in Hartford, CT effective September 16. The MSA covers natural gas pipeline services in Connecticut and other locations, as may be agreed upon, over a period of three years with a two-year optional extension. Specifically, Williams will be tasked with the installation, maintenance, repair and other services associated with the natural gas distribution systems covered under this agreement. Additional terms were not disclosed.

08:07 EDT Bionano announces study using OGM to detect BCRs in patients experiencing RPL - Bionano Genomics announced the publication of a study utilizing OGM to detect cryptic balanced chromosomal rearrangements, BCRs, found in subjects who experienced recurrent pregnancy loss, RPL. Compared to traditional cytogenetic methods, OGM successfully identified cryptic reciprocal translocation in all samples, improving the success rate for finding pathogenic variants of cryptic BCRs and streamlining the process of detection. Researchers analyzed samples from 11 couples who dealt with RPL, had a history of an affected child or fetus with chromosome loss or gain, or had a history of infertility to determine OGM's utility for detection of cryptic BCRs, which can significantly increase the risk of delivering abnormal offspring with congenital malformations or miscarriage for carrier couples. OGM showed 100% concordance with the results from fluorescence in situ hybridization and sequencing analyses and revealed additional complex rearrangement events such as inverted aberrations, further refining potential genetic interpretation.

08:06 EDT Sesen Bio and Carisma Therapeutics announce merger agreement - Sesen Bio and Carisma Therapeutics , a privately held, clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on the advancement of Carisma's proprietary cell therapy platform that utilizes engineered macrophages and monocytes to potentially transform the treatment of cancer and other serious disorders. Carisma is pioneering the development of chimeric antigen receptor macrophage,CAR-M, therapies and is believed to be the only company developing CAR-M therapies with demonstrated proof of mechanism and safety data in clinical trials. The combined company is expected to operate under the name Carisma Therapeutics and trade on Nasdaq under the ticker symbol "CARM". Carisma has also secured commitments from a syndicate of investors for a $30M financing, including HealthCap, AbbVie, Wellington Partners, SymBiosis, Penn Medicine, TPG Biotech, MRL Ventures Fund, the therapeutics-focused corporate venture arm of Merck & Co., Agent Capital, Solasta, Livzon, Pictet Alternative Advisors and 4Bio, which is expected to close concurrently with the completion of the merger. With the cash expected from both companies at closing and the proceeds of the concurrent financing, the combined company is expected to have approximately $180M in cash, cash equivalents and marketable securities. These cash resources are expected to be used to advance Carisma's pipeline through multiple ongoing and planned key data readouts across several clinical trials and to fund operating expenses and capital expenditure requirements through 2024. The merger and related financing are expected to close in the next three to four months.

08:05 EDT electroCore announces USPTO issued four patents on nVNS - electroCore announced the United States Patent and Trademark Office, USPTO, has issued four patents related to its non-invasive vagus nerve stimulation, nVNS, and other technologies, including the following patents: U.S. Patent No. 11,406,825 entitled "Mobile Phone for Treating a Patient with Dementia" issued on August 9, 2022. This patent is generally related to nVNS therapies for treating neurodegenerative diseases with a stimulator coupled to a mobile device; U.S. Patent No. 11,432,760 entitled "Devices and Methods for Remote Therapy and Patient Monitoring" issued on September 6, 2022. This patent is generally related to nVNS that includes a stimulator coupled to a mobile device capable of transmitting data to the mobile device that includes, among other things, the position of the electrode on the skin surface relative to the target nerve; U.S. Patent No. 11,439,818 entitled "Electrical Nerve Stimulation to Treat Gastroparesis, Functional Dyspepsia, and Other Functional Gastrointestinal Disorders" issued on September 13, 2022. This patent is generally related to nVNS therapies for treating post-operative ileus; and U.S. Patent No. 11,446,491 entitled "Stimulator for Use with a Mobile Device" issued on September 20, 2022. This patent is another in the series of patents that electroCore has received which are generally related to the use of nerve stimulators with mobile devices, such as a mobile phone. "We are pleased to be granted these four new patents by the USPTO, which strengthen our intellectual patent portfolio," stated Dan Goldberger, Chief Executive Officer of electroCore. "These new patents support our mobile connectivity platform, by using mobile devices coupled with a stimulator to deliver nVNS therapy. The addition of these patents underscores our commitment to advancing therapy beyond those who suffer from migraines and cluster headaches, and we look forward to continuing to explore the role of nVNS for various conditions."

08:04 EDT Pulse Biosciences announces strategic change of focus, job cuts - Last night, Pulse Biosciences announced a shift in focus to advance its core technology and the CellFX System powered by Nano-Pulse Stimulation technology. "Implementing the present time strategic opportunities does not require the significant sales, marketing and related administrative support team that has been in place. Accordingly, headcount now stands at 66 employees principally focused on engineering, business development and related new product support personnel. In June of 2022, Pulse Biosciences employed 121 employees. The vast majority of present time reduction in personnel mainly impacts dermatological sales, marketing and related support activities. Along with minimizing commercial activities, the Company plans to evaluate potential partners in the dermatology space. Additionally, the company plans to hold an Investors Day in the next 60 days to show progress and highlight the promising opportunities in other health care verticals. In support of the change in strategy, Mr. Duggan, the majority shareholder and Executive Chairman, and the company have entered into a loan agreement in which Mr. Duggan has agreed to loan the company $65 million to fund its product development operations," the company stated. "With the full backing of our board to make the shift in strategy at this time, I look forward to expanding into other areas of healthcare that can leverage our unique NPS technology," said Kevin Danahy, Pulse Biosciences President and CEO. "Shifting our strategy aligns with our ability to demonstrate our proven mechanism of action and the safety and efficacy of our technology as it relates to other markets. I am excited to have the opportunity to collaborate with this top-quality executive team through our next phase of growth."

08:02 EDT Pacira says Phase 3 study of EXPAREL achieves primary, secondary endpoints - Pacira BioSciences announcedtopline results from its Phase 3 study of EXPAREL as a single-dose sciatic nerve block in the popliteal fossa for postsurgical regional analgesia in patients undergoing bunionectomy. EXPAREL achieved the study's primary endpoint by demonstrating a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine HCl. EXPAREL also achieved statistical significance for reduction in postsurgical opioid consumption and percentage of opioid-free subjects through 96 hours compared with bupivacaine HCl, which were key secondary endpoints. EXPAREL was well tolerated with a safety profile consistent with bupivacaine HCl. "With the successful readout of our second Phase 3 study, we now have an overwhelmingly positive body of data supporting EXPAREL as the first and only single-dose product to safely demonstrate four days of superior pain control versus bupivacaine," said Dave Stack, chairman and CEO of Pacira BioSciences. "EXPAREL-based nerve and field blocks are fueling a revolution in regional aesthesia. With these positive data sets, we believe we are well positioned to broaden the EXPAREL label to include two additional nerve block indications for prolonged pain management across a wide variety of lower extremity procedures. This will help physicians improve their patients' outcomes by providing better pain control, while minimizing opioids, accelerating recovery times, and migrating procedures to outpatient settings." Pacira plans to submit a supplemental New Drug Application to the U.S. Food and Drug Administration early next year to expand the EXPAREL label to include sciatic nerve blocks in the popliteal fossa, as well as femoral nerve blocks in the adductor canal. Earlier this month, Pacira announced positive results from a Phase 3 study of EXPAREL as a single-dose femoral nerve block in the adductor canal for total knee arthroplasty. A sciatic nerve block in the popliteal fossa is used for anesthesia and analgesia for foot, ankle, achilles tendon, and other lower leg surgeries. A femoral nerve block in the adductor canal is used for anesthesia and analgesia for surgery of the knee, medial lower leg, and ankle surgeries.

08:02 EDT PDS announce CPI patients selected for ongoing development of PD10101 therapy - PDS Biotechnology announced that checkpoint inhibitor, CPI, refractory patients have been selected as the optimal treatment group in the ongoing development of the PDS0101-based triple combination therapy in advanced HPV-positive cancers. After consulting with PDS Biotech, the study, conducted at the Center for Cancer Research at the National Cancer Institute, one of the Institutes of the National Institutes of Health, has been closed to further enrollment given that the CPI refractory arm has been fully recruited. PDS Biotech and the NCI CCR plan to meet with the U.S. Food and Drug Administration in the coming months to discuss the registrational path forward for the PDS0101-based triple combination therapy as a potential third-line treatment for CPI refractory, HPV-positive cancers. The NCI-led Phase 2 clinical trial is investigating PDS0101 in combination with two investigational immune-modulating agents - M9241, a tumor-targeting IL-12, and bintrafusp alfa, a bifunctional checkpoint inhibitor - in recurrent or metastatic HPV-positive cancers in patients who have failed at least two standard of care therapies including CPI treatment. Both M9241 and bintrafusp alfa are owned by Merck KGaA. Data from this study, as presented at ASCO 2022, demonstrated that the triple combination therapy resulted in a 77% survival at a median of 12-months of follow-up in CPI refractory patients. Historical median survival rates for CPI refractory patients are 3-4 months. The triple combination therapy also appeared to be safe and well-tolerated with Grade 3 and Grade 4 treatment-related adverse events reported. "The data generated in the CPI refractory arm of the Phase 2 trial investigating the PDS0101-based triple combination in advanced HPV-positive cancers seems compelling and potentially provides a foundation for advancing this program into late-stage clinical development," stated Dr. Frank Bedu-Addo, President and Chief Executive Officer of PDS Biotech. "For patients with CPI refractory HPV-associated disease, there is no clear effective standard of care therapy despite the severity of the disease. We intend to focus on the development of the triple combination therapy specifically for this patient group given the extreme unmet need coupled with the signals of efficacy observed in the CPI refractory Phase 2 trial arm. We believe this represents a significant value-building opportunity for PDS Biotech and our shareholders."

07:47 EDT Jacobs awarded contract by South Korean wind farm project developer Elenergy - Jacobs has been awarded a contract by South Korean offshore wind farm project developer, Elenergy, to complete the feasibility study for a new green hydrogen production and import facility in South Korea. The facility will provide locally produced and imported green hydrogen for South Korea and help advance the country's plans to transition to a clean energy economy, where hydrogen will account for 33% of energy consumption and 23.8% of power generation by 2050. The facility will be powered by 100% renewable wind energy sourced from the 1.5GW Chujin Offshore Wind Farm which Elenergy is also currently developing. Jacobs will conduct a green hydrogen market analysis and technology review, develop the conceptual design and conduct business case assessment for setting up a green hydrogen production facility.

07:39 EDT Rekor Systems announces introduction of Rekor Partner Network - Rekor Systems announced the introduction of its Rekor Partner Network. The Rekor Partner Network is designed to aggregate, transform, and deliver actionable insights and analytics as a service from a global ecosystem of connected vehicles, navigation, work zone, weather, roadway sensor and special event data companies. Together, RPN partners can provide even more powerful and effective solutions to customers.

07:36 EDT Tiziana Life Sciences announces purchase of common shares by chairman - Tiziana Life Sciences announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 20,145 common shares priced between $0.66 per share. The acquisition takes Mr Cerrone's interests from 37.72% to 37.74%.

07:35 EDT Almaden signs new, expanded cooperation agreements with Ixtaca groups - Almaden Minerals reports it has recently signed two new agreements with not-for-profit organizations established by inhabitants of the local towns of Zacatepec and Santa Maria Zotoltepec, the two communities closest to the Ixtaca project, in Puebla State, Mexico. These agreements set out the terms of the Company's continued support of local communities' human right to water through the immediate improvement of local water infrastructure, and establish a basis for longer term cooperation. In Zacatepec, the Company has reaffirmed its agreement with the "Irrigation Group of Small Producers from Zacatepec A.C.", first announced in March, 2020, wherein it committed to work with them and Mexico's water authority to construct an agricultural water reservoir and related pumping and drip irrigation system to support local farming. In Santa Maria Zotoltepec, the Company has signed an agreement with the "United Ejidatarios for the Sustainable Development of Santa Maria Zotoltepec, A.C." in which the Company will make an immediate contribution in order to support the construction of a similar agricultural reservoir and pumping and drip irrigation system with similar characteristics to the one built at Zacatepec. Duane Poliquin, Chair of Almaden, stated "We are pleased to continue providing immediate, tangible and effective support to local communities on one of their key human rights priorities, the human right to water. At Zacatepec, we have seen how effective the agricultural reservoir has been and are excited to see Santa Maria Zotoltepec benefit from similar development. Perhaps more importantly, these agreements set us up to deliver, together with community members, on the important elements set out in the Company's Human Rights Policy such as water rights, education, health, opportunity, workers' rights, environment, culture, and more. We look forward to continued culturally pertinent collaboration and information sharing with these and other groups in order to properly seize the opportunity presented by the Ixtaca project."

07:33 EDT Tutor Perini selected as design, construction contractor for I-270 project - Tutor Perini (TPC) announced that it has been selected by Accelerate Maryland Partners as the design and construction contractor for Phase 1 South of the New American Legion Bridge I-270 Traffic Relief Plan, one of the largest civil works projects ever undertaken in the United States. Tutor Perini was selected by AM Partners to design and construct both the Phase 1 South A and Phase 1 South B components of the project. Tutor Perini's team includes O&G Industries, the Company's subsidiary - Lunda Construction, as well as Parsons (PSN) as the lead designer for both Phase 1 South A and B components. Phase 1 South and Phase 1 North of the New American Legion Bridge I-270 Traffic Relief Plan are expected to generate $12.6B in construction-related economic activity, support 43,400 job-years of employment and boost regional labor income by more than $3.3B, based on a 2022 assessment report conducted by the Center for Regional Analysis at George Mason University. Phase 1 South is a multi-billion dollar construction project.

07:32 EDT Adamis Pharmaceuticals says DSMB recommends halting Phase 2/3 trial of Tempol - Adamis Pharmaceuticals announced that the third planned interim analysis of the Phase 2/3 clinical trial examining the effects of Tempol in high risk subjects with early COVID-19 infection did not achieve its primary endpoint, as measured by comparing the rate of sustained clinical resolution of symptoms of COVID-19 at day 14 of Tempol versus placebo. The independent Data Safety Monitoring Board recommended that the study be halted early due to lack of efficacy. The DSMB did note that no safety concerns were identified in the subjects that received Tempol. Based on the recommendation from the DSMB, the Company has halted the trial and will now evaluate the unblinded data from the trial to determine the next developmental steps for Tempol. "We are obviously disappointed that the study did not meet its endpoints," said Ron Moss, MD, CMO of Adamis. "Much of the preclinical work on Tempol for COVID-19 examined the effects of the drug on severe illness. This trial did not meet its primary endpoint, but we are exploring the possibility that vaccinations and the less virulent variants during the trial period may have obscured an effect of Tempol. This speculation is based on the lower-than-expected observed hospitalization rate in this trial compared to other COVID-19 treatment trials. We will continue to analyze the data to determine if we believe Tempol can be utilized in other COVID patient populations including those with more severe illness or immunocompromised. I would like to thank our clinical research partners, the trial investigators and all the trial subjects for their participation."

07:29 EDT Glatfelter drops 15% to $3.98 after suspending dividend

07:14 EDT Greenwave Technology on track to complete scrapping cranes by Sept. 30 - Greenwave Technology Solutions announced that it is on track to complete the scrapping of three ship-to-shore cranes at the Port of Virginia by September 30, 2022. The cranes, which are estimated to weigh 3,200 tons, are being dissembled by Crofton Industries with Greenwave processing and selling the scrap metal.

07:10 EDT Crew Energy achieves ceritfication under EO100 Standard - Crew Energy announced that it has achieved independent certification of its natural gas and natural gas liquids production from the NE BC Development area under the Equitable Origin EO100 Standard for Responsible Energy Development.

07:08 EDT Magnolia Oil & Gas appoints Christopher Stavros CEO - Magnolia Oil & Gas announced that Christopher Stavros, the Company's current Executive Vice President and Chief Financial Officer, has been named President and Chief Executive Officer, and has been appointed to the Board of Directors, effective immediately. Stephen Chazen, who has served as Chairman, President and Chief Executive Officer since 2018 will no longer be able to serve in his positions due to serious health reasons. "First and foremost, we would like to extend our deep support to Steve's family," said Dan Smith, who previously served as Magnolia's Lead Independent Director and has been named as Chairman of the Board. "Steve is an exceptionally talented and revered leader, who will leave an extraordinary legacy on our industry. Not only has Steve led an evolution of Magnolia, but his influence has also shaped the oil & gas landscape and the greater business and Houston communities. He cares deeply about Magnolia and our employees and created opportunities for many throughout his career. We share a commitment to carrying out the initiatives Steve developed, both inside Magnolia and in our local communities."

07:07 EDT Castle presents clinical scenarios for GEP tests at NP+PA Fall conference - Castle Biosciences provided a proposed framework of the Company's diagnostic gene expression profile or GEP tests, MyPath Melanoma and DiffDx -Melanoma, for use in clinical practice to help achieve personalized management and treatment plans. The data is being shared during the Maui Derm NP+PA Fall 2022 Conference, being held Sept. 18-21 in Nashville, Tennessee, and virtually, Sept. 19-21. MyPath Melanoma and DiffDx-Melanoma are Castle's diagnostic GEP tests designed to provide objective, accurate results to aid in the diagnosis of ambiguous melanocytic lesions. The tests can provide clinically actionable information to help guide and potentially increase confidence in a diagnosis, if any uncertainty or discordance exists, to help clinicians deliver more informed patient management plans and provide their patients with more appropriate and individualized care.

07:05 EDT Fennec announces FDA approval of PEDMARK - Fennec Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved PEDMARK to reduce the risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors. This approval makes PEDMARK the first and only treatment approved by the FDA in this area of significant unmet medical need. "The FDA approval of PEDMARK represents an important breakthrough for pediatric patients with localized, non-metastatic solid tumors at risk for cisplatin-induced hearing loss. Cisplatin is a critical, standard of care agent, used in the treatment of pediatric cancers; however, even though effective, it could be harmful to children, frequently causing permanent and irreversible bilateral hearing loss. With PEDMARK, physicians now have an approved treatment option to reduce the risk of cisplatin-induced hearing loss in pediatric patients," said Rosty Raykov, chief executive officer of Fennec Pharmaceuticals. "We would like to thank the patients, their families, physicians, investigators, employees, consultants and the entire research team at Oregon Health and Science University, who have contributed to the development of PEDMARK." The FDA approval of PEDMARK was based upon safety and efficacy data from two pivotal open-label, randomized Phase 3 trials, which compared PEDMARK plus cisplatin-based regimen to cisplatin-based regimens alone for the reduction of cisplatin-induced hearing loss in pediatric patients. In both studies, the incidence of hearing loss was consistently and significantly lower in the PEDMARK plus cisplatin arm compared with the cisplatin alone arm.

07:03 EDT Matinas BioPharma announces Chairman succession plan - Matinas BioPharma announced its leadership succession plan, with the Board of Directors unanimously appointing current board member, Eric Ende, to succeed Herbert Conrad as Chairman of the Board. Conrad, the founding Chairman of Matinas, will remain on the Board as an independent director of the Company. The succession will be effective October 1, 2022. Dr. Ende joined the Company's Board of Directors in March 2017.

06:58 EDT Azure Power announces Shweta Srivastava as chief human resource officer - Azure Power announced Shweta Srivastava as its chief human resource officer, or CHRO. In her new role, Srivastava will be responsible for leading human resource strategy in support of the overall business plan and strategic direction of the company, specifically in the areas of succession planning, talent management, change management, organizational and performance management, training and development, and compensation.

06:45 EDT United Therapeutics announces termination of PERFECT clinical study of Tyvaso - In a regulatory filing on Tuesday, September 20, United Therapeutics announced the termination of the PERFECT clinical study evaluating Tyvaso Inhalation Solution for the treatment of pulmonary hypertension associated with chronic obstructive pulmonary disease. The company terminated the study based upon a recommendation of the study's independent Data Safety Monitoring Committee, or DSMC, following a routine safety and efficacy analysis conducted by the DSMC. "The company will review the available data from the study and plans to share the results with the scientific community," the filing stated. United Therapeutics closed yesterday at $207.18, falling about 4% for the day.

06:34 EDT Trilogy Metals provides update on Ambler Access Project - Trilogy Metals is providing an update on the Ambler Access Project, or AAP, the proposed 211-mile, industrial-use-only road from the Upper Kobuk Mineral Projects, or UKMP, to the Dalton Highway. The United States Bureau of Land Management, or USBLM, has published in the Federal Register a Notice of Intent, or NOI, that it will prepare a Supplemental Environmental Impact Statement, or SEIS, for the proposed Ambler Mining District Industrial Access Road. The NOI indicates that: The USBLM will accept comments related to the SEIS for 45 days so that the USBLM can determine which, if any, additional impacts and resources related to identified deficiencies should be more thoroughly assessed to facilitate integrating the USBLM's National Environmental Policy Act analysis with its ongoing Alaska National Interest Lands Conservation Act Section 810 and National Historic Preservation Act Section 106 processes; Input by Alaska Native Tribes and Corporations will continue to be of critical importance and that USBLM will continue to consult with these entities under applicable guidance; and Preparation of the SEIS in compliance with NEPA will additionally help the USBLM to fulfill its obligations under applicable law. The USBLM has said it anticipates publishing a Draft SEIS during the second quarter of 2023, after which it will accept public comments on the Draft SEIS.

06:32 EDT Clearway Energy provides operational update on El Segundo Energy Center - Clearway Energy announced that beginning on August 29th, the El Segundo Energy Center began a forced outage at Units 7 and 8 due to damage of a portion of the tube bundles used to condense steam. After initial repairs, both Unit 7 and 8 returned to service on September 14th. In consultation with the company's Operations and Maintenance service provider, the Company plans to replace the remaining tube bundles at Unit 7 and 8. The company estimates the cash impact related to the forced outage due to lost revenue, O&M, and capital expenditures to be approximately $10M-12M in 2022. Management will provide an update to 2022 financial guidance and initiate 2023 financial guidance as part of its third quarter 2022 earnings update. The company is reiterating its target to achieve the upper range of its 5%-8% annual dividend growth objective through at least 2026.

06:27 EDT Novartis to petition U.S. Supreme Court on Gilenya dosing regimen patent - Novartis announced that the U.S. Court of Appeals for the Federal Circuit, or CAFC, has denied its petition to rehear the negative decision regarding the validity of US Patent No. 9,187,405, covering a dosing regimen for 0.5mg Gilenya. Novartis plans to file a petition seeking further review of the CAFC's decision with the US Supreme Court. "In August 2020, the U.S. District Court for the District of Delaware issued a favorable decision and a permanent injunction was granted against HEC Pharma until the expiration of the '405 patent in December 2027, including pediatric exclusivity. HEC Pharma was the only remaining Abbreviated New Drug Application, ANDA, filer challenging this patent. In January 2022, a three-judge panel of the CAFC issued a decision upholding the validity of the dosing regimen patent. HEC subsequently filed a petition for rehearing with the CAFC and, in June 2022, a modified panel from the CAFC issued a reversal of its previous decision and found the patent invalid. Should generics launch in the US, we expect FY 2022 sales to be negatively impacted by USD 0.3bn. With regard to 2022 Full Year Guidance for Group sales and core operating income growth, we continue to expect both in the mid-single digit range, in constant currencies. Novartis intends to vigorously defend the validity of the patent and is considering all available options, including current plans to seek review of this decision by petition to the US Supreme Court, a process which may take several months to determine if the petition will be granted. Previously, Novartis entered into settlement agreements with a number of ANDA filers. Under these settlements, those ANDA filers would have been able to launch a generic version of Gilenya, if approved by FDA, on an agreed upon date that is prior to the expiration of the dosing regimen patent, or earlier than the agreed upon date under certain circumstances. With this decision, HEC and other ANDA filers with FDA approval will potentially be able to launch a generic version of 0.5mg Gilenya imminently, pending any other judicial actions," the company stated.

06:07 EDT Clever Leaves announces partnership with House of Kush - Clever Leaves Holdings announced a partnership with U.S. cannabis-branded genetic innovation company, House of Kush, to be the exclusive grower and distributor of proprietary genetics globally. Clever Leaves will be the exclusive producer of various genetics for House of Kush outside of the U.S. and Canada. As the exclusive grower for House of Kush globally, Clever Leaves will cultivate and commercialize House of Kush proprietary genetics in its Colombia and Portugal facilities for the duration of the three-year agreement, after completing an initial evaluation and adaptation phase of the genetics for each production location. This partnership will further strengthen Clever Leaves' portfolio of high THC smokable flower which is already being sold in Germany, Israel, and Australia.

06:05 EDT Amazon.com adds 2.7GW of clean energy - Amazon announced that it is expanding its renewable energy portfolio globally, with an additional 2.7 gigawatts of clean energy capacity across 71 new renewable energy projects. This includes the company's first renewable energy project in South America-a solar farm in Brazil-and its first solar farms in India and Poland. Once fully operational, Amazon's global renewable energy portfolio will generate 50,000 gigawatt hours of clean energy, which is the equivalent amount of electricity needed to power 4.6M U.S. homes each year. Amazon co-founded The Climate Pledge in 2019, committing to reach net-zero carbon by 2040-10 years ahead of the Paris Agreement.

06:03 EDT IGC announces issuance of second patent for Alzheimer treatment from USPTO - India Globalization Capital, or IGC, announced that the U.S. Patent and Trademark Office, or USPTO, issued a second patent for the treatment of Alzheimer's disease entitled "Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer's disease." The original patent application was initiated by the University of South Florida and filed on July 30, 2015. On May 25, 2017, IGC entered into an exclusive license agreement with USF with respect to the patent application and the associated research conducted on Alzheimer's disease. The Company's subsidiary, IGC Pharma, used some of the research to develop an oral formulation, IGC-AD1. Based on the USF research on Alzheimer's cell lines, subject to further testing and clinical trials, testing indicates that on a dose dependent manner, the active agents in IGC-AD1 may ameliorate Ass plaque and decrease ptau, a phosphorylated protein responsible for tangles in neurons.

05:34 EDT Air Liquide, Chevron and others to form CCUS solutions consortium in Singapore - Air Liquide (AIQUY), Chevron (CVX), Keppel Infrastructure and PetroChina announced they have signed a memorandum of understanding to form a consortium which will aim to evaluate and advance the development of large-scale carbon capture, utilization, and sequestration, or CCUS, solutions and integrated infrastructure in Singapore. The consortium intends to research, test, and develop technological, logistical, and operational solutions for CCUS in Singapore. In doing so, the consortium will look to provide industry-wide CCUS integrated infrastructure, primarily to support the energy and chemicals sector, by capturing and aggregating carbon dioxide from large industrial emitters at a centralized collection facility. The CO2 could then be utilized to make useful products, such as plastics, fuels, and cement, and/or transported through either pipelines or ships to suitable reservoirs in the Asia Pacific region for sequestration via a process of injecting CO2 into deep underground geologic formations for permanent and secure storage.

05:27 EDT Argenx submits SC efgartigimod BLA to FDA - Argenx (ARGX) announced the submission of a Biologics License Application, or BLA, to the FDA for SC efgartigimod for the treatment of generalized myasthenia gravis, or gMG, in adult patients. SC efgartigimod is co-formulated with recombinant human hyaluronidase PH20, Halozyme's (HALO) Enhanze drug delivery technology. Enhanze facilitates the subcutaneous injection delivery of biologics that are typically administered via intravenous, or IV, infusion.

05:21 EDT Cognizant enters multi-year partnership with Freshfields Bruckhaus Deringer - Cognizant announced that it has been selected by global law firm Freshfields Bruckhaus Deringer to manage global IT operations and support its ambitious global expansion plans. Under the new multi-year agreement, Cognizant will provide a 24x7 managed service of Freshfields' IT infrastructure and applications, as well as managing its service desk. Cognizant will also help define Freshfields' technology transformation roadmap.

05:18 EDT Paysafe enters new partnership with Spreedly - Paysafe announced a new partnership with Spreedly, a global payments orchestration platform provider, to offer Paysafe's payment gateway to Spreedly's international merchant base. Paysafe joins Spreedly's Partnership Program to become part of its ecosystem which offers multiple payments services globally, with 120+ available integrations from a single point of connection. Through Paysafe's payment gateway, merchants are able to process card transactions seamlessly across multiple countries and currencies. Using Paysafe's services, merchants can accept payments in over 40 currencies and support a large range of local payment methods, underpinned by the deep regulatory expertise and compliance required to process cross-border payments effectively and expand into new regions. The partnership between Paysafe and Spreedly initially launched in the UK and Europe, with a particular focus on e-commerce, retail, travel, crypto, and financial services where both companies have a strong existing footprint. The two companies plan to extend the partnership into North America and Latin America.